It has been a long time since Pfizer (PFE) initiated a strategic review of its business units and in the meantime, there has been much speculation regarding which units the company would ultimately divest and the method of any such divestiture. After months of waiting (kind of reminds me of the Dwight Howard situation, except far less interesting),… Read More »
It looks like Pfizer (PFE) is moving ahead with its plans to divest its animal health unit. The latest sign is a recent restructuring of its Indian subsidiary’s animal health unit which was folded into the company’s larger animal health division. According to a Pfizer spokeswoman, ‘“in order for any potential transaction with animal health, in some countries… Read More »
A few months ago, pharma giant Pfizer (PFE) got a boost when Sanford Bernstein analyst Tim Anderson (and a few other street colleagues) mentioned that company management was open to spinning off or selling parts of the business. This set off a flurry of reports analyzing potential castaways with estimates ending up as high as 4 divisions shed… Read More »